Literature DB >> 19459819

Aspergillus colonization of the lung allograft is a risk factor for bronchiolitis obliterans syndrome.

S S Weigt1, R M Elashoff, C Huang, A Ardehali, A L Gregson, B Kubak, M C Fishbein, R Saggar, M P Keane, R Saggar, J P Lynch, D A Zisman, D J Ross, J A Belperio.   

Abstract

Multiple infections have been linked with the development of bronchiolitis obliterans syndrome (BOS) post-lung transplantation. Lung allograft airway colonization by Aspergillus species is common among lung transplant recipients. We hypothesized that Aspergillus colonization may promote the development of BOS and may decrease survival post-lung transplantation. We reviewed all lung transplant recipients transplanted in our center between January 2000 and June 2006. Bronchoscopy was performed according to a surveillance protocol and when clinically indicated. Aspergillus colonization was defined as a positive culture from bronchoalveolar lavage or two sputum cultures positive for the same Aspergillus species, in the absence of invasive pulmonary Aspergillosis. We found that Aspergillus colonization was strongly associated with BOS and BOS related mortality in Cox regression analyses. Aspergillus colonization typically preceded the development of BOS by a median of 261 days (95% CI 87-520). Furthermore, in a multivariate Cox regression model, Aspergillus colonization was a distinct risk factor for BOS, independent of acute rejection. These data suggest a potential causative role for Aspergillus colonization in the development of BOS post-lung transplantation and raise the possibility that strategies aimed to prevent Aspergillus colonization may help delay or reduce the incidence of BOS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19459819      PMCID: PMC4214373          DOI: 10.1111/j.1600-6143.2009.02635.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  40 in total

1.  Protease-dependent activation of epithelial cells by fungal allergens leads to morphologic changes and cytokine production.

Authors:  H F Kauffman; J F Tomee; M A van de Riet; A J Timmerman; P Borger
Journal:  J Allergy Clin Immunol       Date:  2000-06       Impact factor: 10.793

Review 2.  Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria.

Authors:  Marc Estenne; Janet R Maurer; Annette Boehler; James J Egan; Adaani Frost; Marshall Hertz; George B Mallory; Gregory I Snell; Samuel Yousem
Journal:  J Heart Lung Transplant       Date:  2002-03       Impact factor: 10.247

Review 3.  Spectrum of Aspergillus infection in lung transplant recipients: case series and review of the literature.

Authors:  B Mehrad; G Paciocco; F J Martinez; T C Ojo ; M D Iannettoni; J P Lynch
Journal:  Chest       Date:  2001-01       Impact factor: 9.410

4.  Aspergillus infection in lung transplant recipients with cystic fibrosis: risk factors and outcomes comparison to other types of transplant recipients.

Authors:  Mohamed Helmi; Robert B Love; Debbie Welter; Richard D Cornwell; Keith C Meyer
Journal:  Chest       Date:  2003-03       Impact factor: 9.410

5.  Nebulized amphotericin B prophylaxis for Aspergillus infection in lung transplantation: study of risk factors.

Authors:  V Monforte; A Roman; J Gavalda; C Bravo; L Tenorio; A Ferrer; J Maestre; F Morell
Journal:  J Heart Lung Transplant       Date:  2001-12       Impact factor: 10.247

6.  Outcome of lung transplantation in patients with mycetomas.

Authors:  Denis Hadjiliadis; Thomas A Sporn; John R Perfect; Victor F Tapson; R Duane Davis; Scott M Palmer
Journal:  Chest       Date:  2002-01       Impact factor: 9.410

Review 7.  Putative virulence factors of Aspergillus fumigatus.

Authors:  J F Tomee; H F Kauffman
Journal:  Clin Exp Allergy       Date:  2000-04       Impact factor: 5.018

8.  Investigation and control of aspergillosis and other filamentous fungal infections in solid organ transplant recipients.

Authors:  J E Patterson; J Peters; J H Calhoon; S Levine; A Anzueto; H Al-Abdely; R Sanchez; T F Patterson; M Rech; J H Jorgensen; M G Rinaldi; E Sako; S Johnson; V Speeg; G A Halff; J K Trinkle
Journal:  Transpl Infect Dis       Date:  2000-03       Impact factor: 2.228

9.  Altered levels of CC chemokines during pulmonary CMV predict BOS and mortality post-lung transplantation.

Authors:  S S Weigt; R M Elashoff; M P Keane; R M Strieter; B N Gomperts; Y Y Xue; A Ardehali; A L Gregson; B Kubak; M C Fishbein; R Saggar; D J Ross; J P Lynch; D A Zisman; J A Belperio
Journal:  Am J Transplant       Date:  2008-07       Impact factor: 8.086

10.  Aspergillus infections after lung transplantation: clinical differences in type of transplant and implications for management.

Authors:  Nina Singh; Shahid Husain
Journal:  J Heart Lung Transplant       Date:  2003-03       Impact factor: 10.247

View more
  60 in total

1.  The Role of TGF-β in the Association Between Primary Graft Dysfunction and Bronchiolitis Obliterans Syndrome.

Authors:  A DerHovanessian; S S Weigt; V Palchevskiy; M Y Shino; D M Sayah; A L Gregson; P W Noble; S M Palmer; M C Fishbein; B M Kubak; A Ardehali; D J Ross; R Saggar; J P Lynch; R M Elashoff; J A Belperio
Journal:  Am J Transplant       Date:  2015-10-13       Impact factor: 8.086

2.  Anti-Aspergillus Prophylaxis in Lung Transplantation: A Systematic Review and Meta-analysis.

Authors:  Archana Bhaskaran; Khalid Mumtaz; Shahid Husain
Journal:  Curr Infect Dis Rep       Date:  2013-12       Impact factor: 3.725

3.  Relationship between trough plasma and epithelial lining fluid concentrations of voriconazole in lung transplant recipients.

Authors:  Siow-Chin Heng; Gregory I Snell; Bronwyn Levvey; Dominic Keating; Glen P Westall; Trevor J Williams; Helen Whitford; Roger L Nation; Monica A Slavin; Orla Morrissey; David C M Kong
Journal:  Antimicrob Agents Chemother       Date:  2013-07-01       Impact factor: 5.191

4.  Systemic sclerosis and bilateral lung transplantation: a single centre experience.

Authors:  R Saggar; D Khanna; D E Furst; J A Belperio; G S Park; S S Weigt; B Kubak; A Ardehali; A Derhovanessian; P J Clements; S Shapiro; C Hunter; A Gregson; M C Fishbein; J P Lynch Iii; D J Ross; R Saggar
Journal:  Eur Respir J       Date:  2010-03-29       Impact factor: 16.671

Review 5.  Lung transplantation: infection, inflammation, and the microbiome.

Authors:  Takeshi Nakajima; Vyachesav Palchevsky; David L Perkins; John A Belperio; Patricia W Finn
Journal:  Semin Immunopathol       Date:  2011-01-27       Impact factor: 9.623

6.  Antifungal prophylaxis in lung transplant: A survey of United States' transplant centers.

Authors:  Kelly M Pennington; Kathleen J Yost; Patricio Escalante; Raymund R Razonable; Cassie C Kennedy
Journal:  Clin Transplant       Date:  2019-06-23       Impact factor: 2.863

7.  Insights from the European Respiratory Society 2018 Annual International Congress in the fields of thoracic surgery and lung transplantation.

Authors:  Rogier A S Hoek; Stelios Gaitanakis; Merel E Hellemons
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

8.  The Perioperative Lung Transplant Virome: Torque Teno Viruses Are Elevated in Donor Lungs and Show Divergent Dynamics in Primary Graft Dysfunction.

Authors:  A A Abbas; J M Diamond; C Chehoud; B Chang; J J Kotzin; J C Young; I Imai; A R Haas; E Cantu; D J Lederer; K C Meyer; R K Milewski; K M Olthoff; A Shaked; J D Christie; F D Bushman; R G Collman
Journal:  Am J Transplant       Date:  2016-11-04       Impact factor: 8.086

9.  Lung-enriched organisms and aberrant bacterial and fungal respiratory microbiota after lung transplant.

Authors:  Emily S Charlson; Joshua M Diamond; Kyle Bittinger; Ayannah S Fitzgerald; Anjana Yadav; Andrew R Haas; Frederic D Bushman; Ronald G Collman
Journal:  Am J Respir Crit Care Med       Date:  2012-07-12       Impact factor: 21.405

10.  Interaction between Pseudomonas and CXC chemokines increases risk of bronchiolitis obliterans syndrome and death in lung transplantation.

Authors:  Aric L Gregson; Xiaoyan Wang; S Sam Weigt; Vyacheslav Palchevskiy; Joseph P Lynch; David J Ross; Bernard M Kubak; Rajan Saggar; Michael C Fishbein; Abbas Ardehali; Gang Li; Robert Elashoff; John A Belperio
Journal:  Am J Respir Crit Care Med       Date:  2013-01-17       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.